15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Marex Group plc Ordinary Shares, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $52.00 to $80.00, a moderate spread. The average target of $71.14 sits 10% above the current $64.65. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.24 next quarter toward $5.82 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Marex Group plc Ordinary Shares.
As of Jul, 7 of 7 firms rate MRX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MRX EPS & revenue forecast
EPS · NEXT QUARTER
$1.24
Range $0.98 – $1.38 · 6 analysts · +29% YoY
Next period, 6 analysts expect Marex Group plc Ordinary Shares to earn $1.24 a share (range $0.98 – $1.38), versus $0.96 a year earlier. Full-year consensus is $5.20, growing to $5.82 the year after.
REVENUE · NEXT QUARTER
$583.1M
Range $540.6M – $597.4M · 6 analysts · +20% YoY
Revenue is expected to reach $583.1M (range $540.6M – $597.4M), +20.3% year-over-year. Full-year consensus is $2.5B, rising to $2.6B next year.
Top analysts covering Marex Group plc Ordinary Shares
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MRX.
#1
Patrick Moley
Piper Sandler · Rank #92
Buy
$75.00+16.0% to target
Overall win rate
42%
+ Follow
#2
Benjamin Budish
Barclays · Rank #101
Buy
$76.00+17.6% to target
Overall win rate
48%
+ Follow
#3
Alexander Blostein
Goldman Sachs
Buy
$62.00-4.1% to target
Coverage
—
+ Follow
#4
BK
Bill Katz
TD Cowen
Buy
$75.00+16.0% to target
Coverage
—
+ Follow
#5
KV
Kyle Voigt
Keefe, Bruyette & Woods
Buy
$54.00-16.5% to target
Coverage
—
+ Follow
MRX stock forecast FAQ
What is MRX's average 12-month price target?+
The 7 analysts with a live target average $71.14 for Marex Group plc Ordinary Shares over the next 12 months, ranging from a $80.00 high to a $52.00 low.
Is MRX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MRX?+
The Street-high target is $80.00 (Jefferies), and the Street-low is $52.00 (Goldman Sachs). The average of all 7 active targets is $71.14.
How many Wall Street analysts cover MRX?+
7 analysts have an active rating on Marex Group plc Ordinary Shares, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering MRX?+
Among analysts who currently cover MRX, Patrick Moley of Piper Sandler has the strongest overall Quantellect track record (Rank #92). Their current call is Buy with a $75.00 target.
What is Marex Group plc Ordinary Shares's projected EPS for next quarter?+
The consensus estimate is $1.24 per share (range $0.98 – $1.38) across 6 analysts. Full-year EPS is projected at $5.20, rising to $5.82 the following year.
How much revenue is Marex Group plc Ordinary Shares expected to report next quarter?+
Consensus revenue is $583.1M (range $540.6M – $597.4M). Full-year revenue is projected at $2.5B, growing to $2.6B next year.
Have analysts been upgrading or downgrading MRX lately?+
As of Jul, 7 of 7 firms rate MRX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MRX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
